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Background: The Hausa/Fulanis in northern Nigeria and other tribal-communities use different parts of Ximenia 
americana for several ailments such as malaria, infectious diseases, fever and constipation with the stem-bark used 
for gastric ulcers.  The plant is one of eight species of Olacaceae family that grows mostly in the tropical countries 
and has common names as sour or monkey plum,  known in the Northern part of Nigeria as ‘Tsada’, in Eastern part  
as ‘Anya Nwona’ and in Western part as ‘Igo’. The study was an attempt to validate the purported ethnomedicinal use 
of the stem-bark of the plant in gastric ulcer. 
Objective: This study investigated the phytochemical constituents of stem-bark extract and its gastro-protective 
potential.   
Methods: Lorke’s acute toxicity-test for oral median lethal-dose (LD50) estimation and preliminary phytochemical 
screening were conducted. The antiulcer effect was evaluated on indomethacin and ethanol induced ulcer-models 
using Wistar rats in two sets of 5-groups of 5 each, starved for 24h. Oral body-weight normal saline(1ml/kg), 
standard-drug (100mg/kg cimetidine or misoprostol) for the respective models and extract-doses (250, 500 and 
1000mg/kg) administered for 30 minutes prior to body-weight 6h indomethacin ulceration  or 1h absolute-
ethanol(1ml) were used. Lesions and larger-diameter (≥3mm) ulcer-spots in isolated-stomachs of euthanized-rats 
were counted.   
Results: The extract contained alkaloids, anthraquinones, carbohydrates, flavonoids, saponins, steroidal-glycosides, 
tannins and terpenoids and significantly (p≤0.05) and dose-dependently reduced mean ulcer-spots as with 
cimetidine and misoprostol.  Reduction was significant only for 500 and 1000mg/kg extract-doses.  Nine severe ulcer-
spots in normal-control rats against 3 in 250 and 500mg/kg groups and none in the 1000mg/kg or cimetidine 
occurred with indomethacin ulcerogen.  Severe ulcer-spots were not found with ethanol-ulcerogen even in normal-
control rats. 
Conclusion: This study therefore, supported the folkloric use of Ximenia americana stembark in ulcer management. 
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1. Introduction 
Plants and herbs are now increasingly being used to 
maintain health and cure many ailments of both mankind 
and animals (WHO, 2013). In addition to essential 
nutrients, food plants also contain natural secondary 
metabolites often referred to as phytochemicals or 
phytoalexins (Hasler and Blumberg, 1999). The 
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medicinal benefits and toxicity potentials of plants are 
related to these active chemical contents and which are 
often not established alongside their essential nutrients. 
These natural organic constituents which vary in type 
and amount with the various parts of a plant are usually 
identified by phytochemical screening (Ekor, 2013). 
Discovering the constituents responsible for the 
medicinal effect of each plant part helps in selecting the 
part with most of the constituents for optimal medicinal 
use and/or effect of the plant.  
Peptic ulcers are parietal painful sores that occur in the 
epithelial lining of the upper gut (stomach, oesophagus, 
or small intestine) due to excess gastric acid secretion 
(Abbas and Kumar, 2010). Stomach ulcer is more 
harmful and if improperly treated often results in life-
threatening complications of medical emergency and 
hospitalisations including abnormal bleeding, 
perforative holes in the walls of stomach and duodenum 
and/or gastric outlet obstruction that may require 
gastric surgery (Bardhan and Royston, 2014). This plant 
had been evaluated for anti-trypanosomal activity 
(Maikai et al, 2008), anti-microbial effect (Ogunleye and 
Ibitoye, 2003) and analgesic activity (Siddaiah et al, 
2009; Soro et al, 2009). The present study is aimed at 
establishing the phytochemical constituents of the 
methanol stem-bark extract of the plant and its efficacy 
in gastric ulcer. 
2. Methods 
2.1 Collection and identification of plant material 
The whole Ximenia americana plant collected in June, 
2014 from Tashan-yari area in  Makarfi Local 
Government Area of Kaduna State (June, 2015) was 
identified and authenticated by a taxonomist, Mallam 
Sanusi of the Department of Biological Sciences, Ahmadu 
Bello University, Zaria by comparing it with an existing 
voucher number 099.  
2.2 Experimental animals 
Adult male Wistar rats (150-200 g) obtained from the 
Animal House Facility of the Department of 
Pharmacology and Therapeutics, Faculty of 
Pharmaceutical Sciences, Ahmadu Bello University, Zaria 
were used for the study. The animals were allowed to 
acclimatise to laboratory conditions with food and water 
provided ad-libitum except when fasting is required.   
All experiments were carried out in compliance with the 
institution’s Ethics in Animal Handling in accordance 
with the regulation for the Care and Use of Laboratory 
animals as accepted internationally (NIH, rev 1996).  
2.3 Drugs and chemical reagents  
All drugs and chemicals used in this study were of 
analytical grade and include: Misoprostol (Cytotec Pfizer 
Inc. IL, USA); Cimetidine (Paucodine / Pauco 
Pharmaceutical Ind. Nig Ltd.); Indomethacin (M/S 
Aphantee Pharm. Nig. Ltd); Ethanol and methanol, 
formaldehyde, Chloroform (BDH Chemical Ltd. Poole 
England). All other chemicals used were also products of 
BDH, England; Mayer and Baker, England and Merck, 
Darmstand, Germany.  
2.4 Preparation of plant extract  
The stem bark of Ximenia americana were scraped off the 
stems of the plant and dried under shade until a constant 
weight was obtained and then crushed into powder. 
Soxhlet extraction method was used whereby the 
obtained powdered material (759 g) was packed into a 
filter thimble underneath a conical flask containing the 
solvent (methanol) and which on heating evaporated 
and condensed through the condenser into the thimble 
for 72 h extraction. The mixture was then filtered to 
obtain the filtrate which was concentrated to dryness 
using a rotary evaporator over water bath at 55 °C to 
obtain the dark-brown methanol extract which was used 
for the study. 
2.5 Determination of phytochemicals 
The qualitative phytochemical analyses were carried out 
according to the methods of Trease and Evans (2002) 
and the constituents investigated for include alkaloids, 
anthraquinone carbohydrates, tannins, sterols, 
terpenoids, saponins, steroidal glycosides. 
2.6 Assessment of mucosal cytoprotective effect of 
X. americana stem bark extract for ulcer inhibition in 
rats 
The method of indomethacin ulceration of Djahanguiri 
(1969) was used. Twenty five (25) rats deprived of food 
for 24 h were divided into five (5) groups of 5 rats each 
and the various groups were treated per body weight for 
30 minutes with normal saline (1 ml/kg), cimetidine 
(100 mg/kg) and extract doses of 250, 500 and 1000 
mg/kg.   Indomethacin (100 mg/kg) was administered to 
all the groups of rats for 6 h ulcer-induction after which 
the rats were anaesthesised with chloroform and the 
abdomen incised to isolate the stomach into 2% v/v 
formal saline overnight. The stomachs were then cut 
open along the greater curvature and spread out on filter 
papers to count the total number of lesions as well as the 
number of ulcer spots of larger diameter ≥ 3mm. 
In another group of experiment, the model of ethanol-
induced ulcers of Robert (1979) was also used. Twenty 
five (25) rats deprived of food for 24 h were divided into 
five (5) groups of 5 rats per group and treated per body 
weight for 30 minutes with normal saline (1 ml/kg), 
misoprostol (100 mg/kg) and extract doses of 250, 500 
and 1000 mg/kg.  Absolute ethanol (1 ml) was then 
administered to all the rats in each group for ulcer 
induction of 1 h after which the rats were sacrificed 
under chloroform anaesthesia and the abdomen incised 
to isolate the stomachs which were then washed and 
spread open on filter papers to count the total number of 
lesions as well as the number of ulcer spots of larger 
diameter ≥ 3mm. 
2.7 Statistical analyses 
Data obtained were presented as tables. The difference 
between means was analysed using one way analysis of 
variance (ANOVA). Dunnett post-hoc test was used to 
obtain Statistical significant differences at p≤0.05.  
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3. Results  
The preliminary phytochemical screening of the 
methanol stem-bark extract of Ximenia americana 
revealed the presence of alkaloids, anthraquinones, 
carbohydrates, flavonoids, saponins, steroidal 
glycosides, tannins and terpenoids. 
Activity against indomethacin-induced ulcers  
The extract significantly and dose-dependently reduced 
the mean ulcer spots in similar manner as the standard 
agent cimetidine.  The reduction was significant only for 
the two higher doses of the extract (500 and 1000 
mg/kg).  However, the ulcer lesions were more 
prevented in the rat groups of cimetidine which showed 
mean ulcer spots of 0.6 ± 0.4 as against 1.80 ± 0.9 of the 
1000 mg/kg extract dose. Only 3 severe ulcer spots for 
each of the two lower extract dose groups against 9 
severe ulcer spots for the normal saline control group 
occurred with indomethacin ulcerogen, with no severe 
ulcer spots in both the cimetidine and 1000 mg/kg 
extract treated rat groups (Table 1). 
Activity against ethanol-induced ulcers  
The ethanol-induced ulcer lesions were also reduced in 
the extract treated groups and similarly, the reduction in 
the ulcer lesions was significant in rats of the two higher 
dose levels of the extract as with indomethacin-induced 
ulcer and both doses prevented the occurrence of lesions 
to same extent. The standard antiulcer drug 
(misoprostol) used for this study also inhibited the ulcer 
spots as expected. There were no severe ulcers (≥ 3mm 
spots) found in any of the groups including the normal 
saline control group (Table 2). 
Table 1:  Effect of X. americana stem-bark extract on indomethacin-induced mucosal lesions in rat 
Treatments 
(per kg) 
Mean ± SEM of ulcer spots 
No. of ulcer spots ≥ 3mm  
(index of severity) 
N/ S (1 ml) 9.20 ± 1.40 9 
EXT 250 mg 6.60 ± 1.07 3 
EXT 500 mg 4.60 ± 0.51* 3 
EXT1000 mg 1.80 ± 0.86* 0 
Cimetidine 100 mg 0.60 ± 0.40* 0 
Data presented as mean±SEM; Statistical tool: one way ANOVA and * = p≤0.05 (Dunnett post-hoc test); Ext=Extract; N/S= normal 
saline; n=5. 
 
Table 2: Effect of X. americana stem-bark extract on ethanol-induced mucosal lesions in rat 
Treatments 
(per kg) 
Mean ± SEM of ulcer spots No. of ulcer spots ≥ 3mm 
(index of severity) 
N/ S (1 ml) 7.60 ± 0.86 0 
EXT250mg 5.20 ± 0.58 0 
EXT500mg 2.40 ± 0.24* 0 
EXT1000mg 2.40 ± 0.40* 0 
Misoprostol 100mg 0.80 ± 0.50* 0 
Data presented as mean±SEM; Statistical tool: one way ANOVA and * = p≤0.05 (Dunnett post-hoc test); Ext=Extract; N/S= normal 
saline; n=5. 
4.0 Discussion 
In addition to essential nutrients, food plants also 
contain natural secondary metabolites of medicinal 
value often referred to as phytochemicals and which vary 
in types and amounts in various plant parts. The 
phytochemical constituents of medicinal plants are often 
responsible for both beneficial and toxicity effects (WHO, 
2004; Ekor, 2013). Any part of a plant of known 
medicinal potentials may be used in particular ailments; 
but for Ximenia americana, the stem-bark is the part 
mostly locally used for antiulcer activity (Desissa and 
Binggeli, 2002; Debela et al, 2012). The optimal 
importance of medicinal plants relies in the use of plant 
parts with the most phytochemical constituent(s) 
responsible for its beneficial effects.  
In this study, the preliminary qualitative phytochemical 
screening showed that the methanol stem bark extract of 
this plant contained alkaloids, anthraquinones, 
flavonoids, saponins, tannins, terpenoids, steroidal 
glycosides and carbohydrates. This finding however, is 
consistent with other works reported with other parts of 
the plant in the literature (Maikai et al, 2008). Some of 
these constituents reported to possess anti-ulcer effects 
include flavonoids and other phenolic compounds which 
prevents gastric mucosal lesions and thus provides the 
cyptoprotective type of antiulcer effect (Zayachikivska et 
al, 2005; Barro et al, 2008). Saponins, tannins and 
terpenoids also possess certain properties related to 
anti-ulcer effect (Borelli and Isso, 2000, Sofidiya et al, 
2012).  Thus, there may be need for quantitative 
phytochemical analysis for the individual components of 
antiulcer activity of this extract.  
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The antiulcer effect of the extract assessed in ulcerogenic 
rats of indomethacin and absolute ethanol-induced 
models in which the cytoprotective barrier mechanisms 
of the mucosal linings are disrupted to cause 
overproduction of acid fluids with ulcers, showed that 
the extract at doses of 500 and 1000 mg/kg significantly 
(p≤0.05) and dose-dependently reduced the mean ulcer 
spots as with the standard drugs, cimetidine and 
misoprostol. However, it was only at the 1000 mg/kg 
extract dose group of the indomethacin ulcer model that 
severe ulcer lesions did not occur as also with cimetidine 
standard antiulcer drug. Each of the two lower extract 
doses showed three (3) severe ulcer spots against nine 
(9) for the normal saline control group. The fewer 
number of severe ulcer spots in the two lower extract 
test group and none in the 1000mg/kg group for 
indomethacin induced ulcer suggests protection. This 
study showed that the higher the dose of the extract, the 
more the protection of ulcer, but there may be concerns 
of possible dose-related toxic effects.  
The absence of severe ulcers in any of the rat groups of 
ethanol-induced ulceration including the normal saline 
control group seemed to suggest that it is a milder 
ulcerative agent than indomethacin which produced 
severe ulcer lesions in the rats of the lower extract doses 
of 250 and 500 mg/kg and also of the normal saline 
control group. Indomethacin causes accumulation of 
cyclic AMP from blockade of prostaglandin production 
(Matsui et al, 2011).  This might have caused an 
increased attack of the gastric acid on the barriers of the 
mucosal wall.  Attack from excess gastric acid from any 
mechanism could be in the form of inhibition of GIT 
mucin production as with the mucinase activity of H. 
pylori or increased gastric emptying of the stomach with 
consequent incomplete neutralisation of the acid (HCl) 
that results in irritation and/or inflammation of the 
mucosa (Pounder et al, 1978). Thus, in addition to 
boosting production of prostaglandins that would stop 
excess acid production, potential antiulcer agents could 
enhance mucosal blood flow functions and/or secretion 
of gastric mucous and bicarbonate which constitute the 
defensive barrier for resisting  acid attack 
(cytoprotection) and/or maintaining  integrity of the 
mucosal wall (Cohen, 1987). Agent for ulcer therapy 
could therefore be of cytoprotectant for increased acid 
resistance or acidity inhibitory to prevent acid 
accumulation.   
5.0 Conclusion  
Antiulcer or gastroprotective effects of the stem-bark 
extract of Ximenia americana were observed, and may 
have been a composite effect of its various 
phytochemicals acting through one or more 
mechanisms. 
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